Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "a significantly lower rate of severe COVID-19" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "the progression of COVID-19 to a severe disease , without increased mortality" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "GnRH neurons activity" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "with both the catalytic residues of SARS CoV-2 Mpro , a key component of viral replication ( His41 and Cys145 )" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "that accounted for a partial and complex cross-over design" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "in adults with COVID-19 disease who require oxygen or mechanical ventilation" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.
- OBJECT label "with a significant reduction in mortality of patients with ARDS due to COVID-19 , most probably via non-specific anti-inflammatory effects" provenance.